• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经内分泌肿瘤患者的健康相关生活质量:一项两波纵向研究。

Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study.

机构信息

Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Sergio Pansini 5, 80131, Naples, Italy.

Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.

出版信息

J Endocrinol Invest. 2022 Nov;45(11):2193-2200. doi: 10.1007/s40618-022-01872-w. Epub 2022 Jul 22.

DOI:10.1007/s40618-022-01872-w
PMID:35867331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9305061/
Abstract

PURPOSE

Scientific knowledge on health-related quality of life (HRQoL) in patients with neuroendocrine neoplasm (NEN) is still limited and longitudinal assessment of HRQoL over the time in NEN patients are scarce. The current study aimed to assess the role of clinical severity and heterogeneity of NEN, as well as resilience, in the HRQoL of NEN patients over the course of a year.

METHODS

39 consecutive NEN patients (25 men and 14 women) aged from 29 to 73 years participated in a longitudinal Italian multicentric study. The main outcome measure concerned the severity and heterogeneity of NEN, HRQoL, and resilience.

RESULTS

Over the course of a year, higher levels of the global health (GH) were associated to the absence of distant metastases, while the presence of metastases with higher levels of fatigue, diarrhea, and financial difficulties. Higher levels of resilience are still associated with better GH and lower levels of fatigue, diarrhea, and financial difficulties, but no longer with constipation. Furthermore, patients with gastroenteropancreatic NEN still have higher scores on constipation, but not on GH, fatigue, diarrhea, and financial difficulties. Patients with hereditary NEN continue to have greater GH than those with a sporadic NEN and lower fatigue, diarrhea, and financial difficulties.

CONCLUSION

These findings showed that the effects of severity and clinical heterogeneity of the NEN on HRQoL may change over time. This evidence should lead clinicians to monitor the HRQoL of NEN patients throughout the course of the disease and psychologists to implement evidence-based resilience interventions.

摘要

目的

关于神经内分泌肿瘤(NEN)患者健康相关生活质量(HRQoL)的科学知识仍然有限,并且对 NEN 患者 HRQoL 的纵向评估也很少。本研究旨在评估 NEN 的临床严重程度和异质性以及韧性在 NEN 患者一年中 HRQoL 中的作用。

方法

39 例连续的 NEN 患者(25 名男性和 14 名女性)年龄为 29 至 73 岁,参加了一项意大利多中心的纵向研究。主要的结局指标是 NEN 的严重程度和异质性、HRQoL 和韧性。

结果

在一年的时间里,更高的全球健康(GH)水平与没有远处转移有关,而存在转移则与更高水平的疲劳、腹泻和经济困难有关。更高的韧性水平仍然与更好的 GH 和更低水平的疲劳、腹泻和经济困难相关,但与便秘无关。此外,胃肠胰腺神经内分泌肿瘤患者在便秘方面的评分仍然更高,但在 GH、疲劳、腹泻和经济困难方面则不然。遗传性 NEN 患者的 GH 仍然高于散发性 NEN 患者,疲劳、腹泻和经济困难程度较低。

结论

这些发现表明,NEN 的严重程度和临床异质性对 HRQoL 的影响可能会随时间而变化。这一证据应促使临床医生在疾病过程中监测 NEN 患者的 HRQoL,并促使心理学家实施基于证据的韧性干预措施。

相似文献

1
Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study.神经内分泌肿瘤患者的健康相关生活质量:一项两波纵向研究。
J Endocrinol Invest. 2022 Nov;45(11):2193-2200. doi: 10.1007/s40618-022-01872-w. Epub 2022 Jul 22.
2
Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience.神经内分泌肿瘤患者的生活质量:严重程度、临床异质性和韧性的作用。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e316-e327. doi: 10.1210/clinem/dgaa760.
3
Fatigue and quality of life in patients with neuroendocrine neoplasia.神经内分泌肿瘤患者的疲劳与生活质量
Scand J Gastroenterol. 2023 Jan;58(1):45-53. doi: 10.1080/00365521.2022.2100228. Epub 2022 Jul 18.
4
Quality of Life in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy: Information from a Monitoring Program in Clinical Routine.胃肠胰神经内分泌瘤转移性患者接受肽受体放射性核素治疗后的生活质量:临床常规监测计划中的信息。
J Nucl Med. 2018 Oct;59(10):1566-1573. doi: 10.2967/jnumed.117.204834. Epub 2018 Jul 24.
5
Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.胃肠胰神经内分泌肿瘤:单中心10年经验
Pol Arch Med Wewn. 2015;125(5):337-46. doi: 10.20452/pamw.2832. Epub 2015 Apr 29.
6
Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.日本胃-肠-胰神经内分泌肿瘤(GEP-NEN)患者的最新流行病学:一项基于人群的研究。
BMC Cancer. 2020 Nov 14;20(1):1104. doi: 10.1186/s12885-020-07581-y.
7
[Analysis of primary site and pathology on 903 patients with neuroendocrine neoplasms].903例神经内分泌肿瘤患者的原发部位及病理分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25;20(9):993-996.
8
The Risk of Second Primary Colorectal Adenocarcinomas Is Not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Nationwide Population-Based Study.胃胰神经内分泌肿瘤患者发生第二原发结直肠腺癌的风险并未增加:一项全国范围内基于人群的研究。
Neuroendocrinology. 2018;107(3):280-283. doi: 10.1159/000492786. Epub 2018 Aug 9.
9
Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in Latvia.拉脱维亚三级转诊医院对胃肠胰神经内分泌肿瘤的流行病学数据及治疗见解
World J Surg. 2020 Feb;44(2):585-593. doi: 10.1007/s00268-019-05219-0.
10
[Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research].[胃肠胰神经内分泌肿瘤——异质性、管理以及治疗与研究的前景]
Internist (Berl). 2020 Aug;61(8):875-890. doi: 10.1007/s00108-020-00832-x.

引用本文的文献

1
Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons.血脂异常、降脂药物与神经内分泌肿瘤:新的前景。
Endocrine. 2024 Aug;85(2):520-531. doi: 10.1007/s12020-024-03767-7. Epub 2024 Mar 20.
2
Younger Age and Parenchyma-Sparing Surgery Positively Affected Long-Term Health-Related Quality of Life after Surgery for Pancreatic Neuroendocrine Neoplasms.较年轻的年龄和保留实质的手术对胰腺神经内分泌肿瘤手术后长期健康相关生活质量有积极影响。
J Clin Med. 2023 Oct 14;12(20):6529. doi: 10.3390/jcm12206529.
3
The unmet information needs, quality of life, and care experiences of patients with neuroendocrine tumours (NETs) at follow-up: 6 months from diagnosis.初诊后 6 个月神经内分泌肿瘤患者的未满足信息需求、生活质量和照护体验
Support Care Cancer. 2023 Sep 15;31(10):577. doi: 10.1007/s00520-023-08034-5.
4
Editorial: Neuroendocrine tumors: the road to precision medicine.社论:神经内分泌肿瘤:精准医学之路
Front Endocrinol (Lausanne). 2023 Jul 26;14:1253319. doi: 10.3389/fendo.2023.1253319. eCollection 2023.
5
Financial well-being as a mediator of the relationship between multimorbidity and health-related quality of life in people with cancer.财务健康作为癌症患者多病共存与健康相关生活质量之间关系的中介。
Cancer Med. 2023 Jul;12(14):15579-15587. doi: 10.1002/cam4.6204. Epub 2023 Jun 7.
6
Psychological distress and resilience in patients with gastroenteropancreatic neuroendocrine tumor.胃肠胰神经内分泌肿瘤患者的心理困扰和韧性
Front Endocrinol (Lausanne). 2022 Nov 16;13:947998. doi: 10.3389/fendo.2022.947998. eCollection 2022.
7
Development and validation of a survival prediction model and risk stratification for pancreatic neuroendocrine neoplasms.胰腺神经内分泌肿瘤生存预测模型的开发与验证及风险分层
J Endocrinol Invest. 2023 May;46(5):927-937. doi: 10.1007/s40618-022-01956-7. Epub 2022 Nov 17.
8
Lipid Metabolism and Homeostasis in Patients with Neuroendocrine Neoplasms: From Risk Factor to Potential Therapeutic Target.神经内分泌肿瘤患者的脂质代谢与稳态:从危险因素到潜在治疗靶点
Metabolites. 2022 Nov 2;12(11):1057. doi: 10.3390/metabo12111057.
9
What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature.高分化神经内分泌肿瘤继发副肿瘤性高钙血症的背后是什么?文献系统综述
J Pers Med. 2022 Sep 21;12(10):1553. doi: 10.3390/jpm12101553.
10
Combined lifestyle, mental health, and mortality in US cancer survivors: a national cohort study.美国癌症幸存者的综合生活方式、心理健康和死亡率:一项全国队列研究。
J Transl Med. 2022 Aug 19;20(1):376. doi: 10.1186/s12967-022-03584-4.

本文引用的文献

1
Stressful Life Events and Resilience During the COVID-19 Lockdown Measures in Italy: Association With Mental Health Outcomes and Age.意大利新冠疫情封锁措施期间的应激性生活事件与心理韧性:与心理健康结果及年龄的关联
Front Psychiatry. 2021 Mar 8;12:635832. doi: 10.3389/fpsyt.2021.635832. eCollection 2021.
2
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?神经内分泌肿瘤的流行病学、发病率和患病率:是否存在全球差异?
Curr Oncol Rep. 2021 Mar 14;23(4):43. doi: 10.1007/s11912-021-01029-7.
3
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: Data from a retrospective multi-centric study.肺癌和胃肠胰神经内分泌肿瘤患者的第二原发性肿瘤:一项回顾性多中心研究的数据
Dig Liver Dis. 2021 Mar;53(3):367-374. doi: 10.1016/j.dld.2020.09.031. Epub 2020 Oct 22.
4
Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience.神经内分泌肿瘤患者的生活质量:严重程度、临床异质性和韧性的作用。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e316-e327. doi: 10.1210/clinem/dgaa760.
5
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet).SARS-CoV2 大流行传播对意大利神经内分泌肿瘤诊治的影响:意大利神经内分泌肿瘤学会(Itanet)报告。
J Endocrinol Invest. 2021 May;44(5):989-994. doi: 10.1007/s40618-020-01393-4. Epub 2020 Aug 16.
6
Resilience process and its protective factors in long-term survivors after lung cancer surgery: a qualitative study.肺癌手术后长期生存者的韧性过程及其保护因素:一项定性研究。
Support Care Cancer. 2021 Mar;29(3):1455-1463. doi: 10.1007/s00520-020-05633-4. Epub 2020 Jul 18.
7
Health-related quality of life in neuroendocrine neoplasia: a critical review.神经内分泌肿瘤患者的生活质量:批判性评价。
Endocr Relat Cancer. 2020 Jul;27(7):R267-R280. doi: 10.1530/ERC-20-0066.
8
Quality of life in "chronic" cancer survivors: a meta-analysis.“慢性”癌症幸存者的生活质量:一项荟萃分析。
J Cancer Surviv. 2020 Aug;14(4):504-517. doi: 10.1007/s11764-020-00869-9. Epub 2020 Mar 11.
9
Cancer-Related Fatigue: Causes and Current Treatment Options.癌症相关性疲劳:病因及现有治疗选择。
Curr Treat Options Oncol. 2020 Feb 5;21(2):17. doi: 10.1007/s11864-020-0707-5.
10
Exploring the relation between patients' resilience and quality of life after treatment for cancer of the head and neck.探索头颈部癌症患者治疗后恢复力与生活质量之间的关系。
Br J Oral Maxillofac Surg. 2019 Dec;57(10):1044-1048. doi: 10.1016/j.bjoms.2019.09.007. Epub 2019 Oct 5.